Insider Transactions in Q2 2021 at Change Healthcare Inc. (CHNG)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Robert Zollars Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+17.76%
|
-
|
|
Jun 22
2021
|
Phillip W. Roe Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+17.76%
|
-
|
|
Jun 22
2021
|
Philip M Pead Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+6.99%
|
-
|
|
Jun 22
2021
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+17.76%
|
-
|
|
Jun 22
2021
|
Bansi Nagji Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+18.41%
|
-
|
|
Jun 22
2021
|
Nella Domenici Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+24.81%
|
-
|
|
Jun 22
2021
|
Kriten Joshi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,518
-10.8%
|
$770,914
$23.15 P/Share
|
|
Jun 22
2021
|
Kriten Joshi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,314
+19.74%
|
-
|
|
Jun 22
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,942
-10.61%
|
$297,666
$23.15 P/Share
|
|
Jun 22
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,888
+21.24%
|
-
|
|
Jun 22
2021
|
Neil E. De Crescenzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
107,249
-10.62%
|
$2,466,727
$23.15 P/Share
|
|
Jun 22
2021
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
272,550
+21.25%
|
-
|
|
Jun 22
2021
|
Howard L Lance Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,136
+3.16%
|
-
|
|
Jun 22
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,535
-6.56%
|
$173,305
$23.15 P/Share
|
|
Jun 22
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,621
+17.65%
|
-
|
|
Jun 17
2021
|
Kriten Joshi Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,718
-4.72%
|
$315,514
$23.07 P/Share
|
|
Jun 17
2021
|
Kriten Joshi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,718
+4.51%
|
-
|
|
Apr 01
2021
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,245
+35.14%
|
-
|
|
Apr 01
2021
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,245
+34.84%
|
-
|
|
Apr 01
2021
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
289,473
+28.19%
|
-
|
|
Apr 01
2021
|
Steven B. Martin EVP, Enterprise Technology |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+18.2%
|
-
|
|
Apr 01
2021
|
Thomas Laur Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+28.59%
|
-
|
|
Apr 01
2021
|
Loretta A. Cecil EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
48,245
+28.18%
|
-
|
|
Apr 01
2021
|
August Calhoun Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+28.57%
|
-
|
|
Apr 01
2021
|
Kriten Joshi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+20.49%
|
-
|
|
Apr 01
2021
|
Roderick H. O'Reilly Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,307
+27.75%
|
-
|
|
Apr 01
2021
|
Fredrik J Eliasson EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
156,798
+28.23%
|
-
|
|
Apr 01
2021
|
Paul Rareshide SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
15,350
+31.14%
|
-
|